Skip to navigation Skip to content

Ethics and compliance

Women sitting on a desk holding tablet chatting with two people

Global business ethics and compliance

Our global business ethics and compliance program is dedicated to ensuring that our business is conducted with integrity and is compliant with applicable laws. This program is led by our Global Chief Compliance Officer, with guidance from our global business ethics and compliance committee. They are supported by regional compliance officers and additional committees.

Corporate policies and procedures

The Apotex Code of Conduct and Business Ethics provides guidance to our team regarding our ethical, legal and compliance principles. The Code of Conduct and Business Ethics is supplemented by various compliance policies, procedures and processes for individual business functions.

Training

Training sessions and educational materials about expectations for compliant and ethical behaviour of employees.

Anonymous and retribution-free reporting

Communication channels and tools for our colleagues, customers and vendors to report concerns or misconduct, anonymously and without reprisals for employees (e.g., the Global Business Ethics and Compliance Helpline, www.APOspeaks.com).

Monitoring and auditing

Systems and procedures to assess adherence to the Code of Conduct and Business Ethics and other compliance related matters, and to identify opportunities for enhancing ethical behaviours.

Investigation and enforcement

Taking appropriate action to validate and address issues, when concerns or allegations about misconduct or non-compliance arise.

Download the Apotex global supplier code of conduct:

Download the Apotex Purchase Order Terms & Conditions:

Download the Apotex Code of Conduct and Business Ethics:

Apotex Annual Declaration of Compliance - California Health & Safety Code § 119402

The Apotex Group of Companies has established a Comprehensive Compliance Program designed to foster compliance with applicable federal and state laws, the U.S. Department of Health and Human Services Office of Inspector General's Compliance Program Guidance for Pharmaceutical Manufacturers, and the Pharmaceutical Research and Manufacturers of America (PhRMA) Code on Interactions with Health Care Professionals.

Based on Apotex's good-faith understanding of the requirements of California Health & Safety Code §§ 119400-119402 and to the best of its knowledge, Apotex declares that, as of July 1, 2026, it is in compliance, in all material respects, with its Comprehensive Compliance Program and the requirements of California Health & Safety Code §§ 119400-119402.

Copies of Apotex's Comprehensive Compliance Program and this Annual Declaration of Compliance may be obtained by emailing [email protected] or calling 1-800-268-4623.